AI Science Tracker

Machine learning generates active daunomycin-binding synthetic nucleic-acid polymers outside selected sequence families

Broad Institute of MIT and Harvard; Harvard University; Massachusetts Institute of Technology; Brigham and Women's Hospital · 4 Aug 2022 · chemistry

Discovery

Machine learning generates active daunomycin-binding synthetic nucleic-acid polymers outside selected sequence families

The study combined in-vitro selection with a conditional variational autoencoder trained on selection data to generate high-affinity highly functionalized nucleic-acid polymer (HFNAP) sequences. Experimentally generated CVAE sequences bound daunomycin with reported dissociation constants of 9–26 nM despite having no apparent primary-sequence similarity to experimentally selected polymers; competition selections found selected generated variants performed as well as or better than sequences obtained after multiple rounds of high-stringency selection.

Technology: Conditional variational autoencoder (CVAE) trained on in-vitro selection-derived HFNAP sequence/fitness data

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Experimentally generated CVAE sequences bound daunomycin with reported dissociation constants of 9–26 nM despite having no apparent primary-sequence similarity to experimentally selected polymers; competition selections found selected generated variants performed as well as or better than sequences obtained after multiple rounds of high-stringency selection.
  • Still unknown: The finding is target binding by synthetic HFNAPs, not therapeutic efficacy or cellular activity. Binding results are specific to daunomycin and reported assays; the authors describe sequences as having no apparent similarity rather than proving wholly unrelated functional mechanisms. Some competition performance was assessed by in-vitro selection rather than a clinical or organism-level test.
  • AI role: The authors used the CVAE to condition generation of novel HFNAP sequences on predicted daunomycin-binding fitness, then synthesized/tested generated sequences in binding and competition-selection assays. The machine-learning model generated the active sequences; wet-lab selection and competition assays established their binding activity.

Evidence sources: https://www.nature.com/articles/s41467-022-31955-4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 79 of works of the same type, year and subfield (OpenAlex work metrics, 23 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.